Page 1,454«..1020..1,4531,4541,4551,456..1,4601,470..»

Regenerative Medicine – AABB

Posted: October 1, 2017 at 10:52 pm

Regenerative medicine may be defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function. This field holds the promise of regenerating damaged tissues and organs in the body by replacing damaged tissue or by stimulating the body's own repair mechanisms to heal tissues or organs. Regenerative medicine also may enable scientists to grow tissues and organs in the laboratory and safely implant them when the body is unable to heal itself. Current estimates indicate that approximately one in three Americans could potentially benefit from regenerative medicine.

Regenerative Medicine refers to a group of biomedical approaches to clinical therapies that may involve the use of stem cells. Examples include cell therapies (the injection of stem cells or progenitor cells); immunomodulation therapy (regeneration by biologically active molecules administered alone or as secretions by infused cells); and tissue engineering (transplantation of laboratory grown organs and tissues). While covering a broad range of applications, in practice the latter term is closely associated with applications that repair or replace portions of or whole tissues (i.e., bone, cartilage, blood vessels, bladder, skin). Often, the tissues involved require certain mechanical and structural properties for proper functioning. The term has also been applied to efforts to perform specific biochemical functions using cells within an artificially-created support system (e.g., artificial pancreas or liver).

Cord blood stem cells are being explored in several applications including Type 1 diabetes to determine if the cells can slow the loss of insulin production in children; cardiovascular repair to observe whether cells selectively migrate to injured cardiac tissue, improve function and blood flow at the site of injury and improve overall heart function; and central nervous system applications to assess whether cells migrate to the area of brain injury alleviating mobility related symptoms, and repair damaged brain tissue (such as that experienced with cerebral palsy). Cord blood stem cells likely will be an important resource as medicine advances toward harnessing the body's own cells for treatment. Because a person's own (autologous) stem cells can be infused back into that individual without being rejected by the body's immune system, autologous cord blood stem cells have become an increasingly important focus of regenerative medicine research.

Regenerative medicine has made its way into clinical practice with the use of materials that are able to assist in the healing process by releasing growth factors and cytokines back into the damaged tissue (e.g., (chronic) wound healing). As additional applications are researched, the fields of regenerative medicine and cellular therapies will continue to merge and expand, potentially treating many disease conditions and improving health for a variety of diseases and health conditions.

Follow this link:
Regenerative Medicine - AABB

Posted in Regenerative Medicine | Comments Off on Regenerative Medicine – AABB

Regenerative Medicine – Health Research Authority

Posted: October 1, 2017 at 10:52 pm

Resource page

For the purposes of the information provided on this page we have adopted the definition of the term regenerative medicine that was used in the House of Lords Regenerative Medicine Report (see below). This was:

regenerative medicine is used to refer to methods to replace or regenerate human cells, tissues or organs in order to restore or establish normal function. This includes cell therapies, tissue engineering, gene therapy and biomedical engineering techniques, as well as more traditional treatments involving pharmaceuticals, biologics and devices.

Each regulator has a clear remit and regulates distinct areas of the regenerative medicine process. However, we work closely together to provide effective advice and guidance to support establishments through the regulatory requirements. Each regulator has a core set of standards that apply depending on where you are in the process, from cell derivation to treatment. We are all focused on ensuring that the standards that are applied at one stage of the process do not act as a barrier at another.

The role of each of the regulators in regenerative medicine is set out below:

Health Research Authority (HRA) has a remit to provide an ethics opinion on clinical trials. Those involving gene therapy regenerative medicines are reviewed through the Gene Therapy Advisory Committee (GTAC). Other regenerative medicine studies may be reviewed by other appropriately flagged RECs. It also provides the Integrated Research Application System (IRAS) through which applications and approvals from GTAC/RECs and MHRA for clinical trials involving regenerative medicines can be made.

Human Fertilisation and Embryology Authority (HFEA)[external link] regulates the use of human embryos or human admixed (human-animal) embryos to derive stem cells for use in the treatment of patients.

Human Tissue Authority (HTA) [external link] remit includes regulation of organisations that remove, store and use of human tissue or cells; this includes where they are used as starting materials for Advanced Therapy Medicinal Products (ATMPs). Under the European Union Tissues and Cells Directives (EUTCD), it licenses establishments that remove, test, process, store, and distribute tissues or cells that will (or may) be used to treat patients.

Medicines and Healthcare products Regulatory Agency (MHRA)[external link] remit includes responsibility for granting the appropriate authorisation for the manufacturing site of ATMPs, which are prepared and used under the hospital exemption, and for ATMPs made and supplied under the specials scheme under the relevant provisions in medicines legislation. In the area of clinical trials, the MHRAs remit includes assessment of applications for clinical trial authorisation and the associated manufacturers licence for investigational ATMPs. The National Institute for Biological Standards and Control (NIBSC) [external link], which houses the UK National Stem Cell bank, is part of the MHRA.

Please refer to the Research Community area of the website for information about the approvals for research studies and how to apply to individual review bodies. Further information about GTAC is also provided on this site. Additionally the Stem Cell Toolkit [external link] provides regulatory routemaps that are specific to individual stem cell projects.

Department for the Environment Food and Rural Affairs (DEFRA) [external link] has an Advisory Committee on Releases to the Environment (ACRE) [external link], which advises government on requests for permission to release genetically modified organisms (GMO) into the environment. In 2013, this committee published advice on gene therapy clinical trial for heart disease.

Health and Safety Executive (HSE) [external link] has the Scientific Advisory Committee on Genetically Modified Organisms (Contained Use) SACGM (CU) [external link]. This committee provides technical and scientific advice to the UK Competent Authorities on all aspects of the human and environmental risks, and is responsible for maintaining guidance on the contained use of GMOs.

From 13 October 2014, the MHRAs Innovation Office is the portal for all regulatory queries concerning regenerative medicines. A one stop shop service provides a single point of access from the four regulators in the field, the Human Tissue Authority (HTA), the Human Fertilisation and Embryology Authority (HFEA), Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA), who will provide a co-ordinated single response service for free regulatory advice.

Any query relating to the regulation of regenerative medicines, including Advanced Therapeutic Medicinal Products (ATMPs) can be submitted to the MHRAs Innovation Office and will be answered by the relevant experts from the four regulatory bodies.

Individuals or companies who have regulatory questions concerning regenerative medicines and who are unsure which agency to direct their inquiry to, or have a query that impacts several regulators, should use the Innovation Office advice form.

The HRA and others work closely together and will continue to engage with those involved in regenerative medicine, including researchers, the British Society for Gene and Stem Cell Therapy [external link], and the Cell Therapy Catapult [external link] to help clarify the regulatory requirements that apply.

The HRA recently held a regenerative medicine event hosted by the Cell Therapy Catapult to look at changes and discuss issues with the sector, regulators and representative bodies. Additionally in 2012, the MHRA hosted an event on the regulation of regenerative medicine [external link].

As set out in the Government Response to the House of Lords Inquiry [external link] a Regenerative Medicine Expert Group (RMEG) is being established to develop an NHS regenerative medicine delivery readiness strategy and action plan. This group will build on existing initiatives so that the NHS is fully prepared to deliver these innovative treatments. The group will be supported by the Department of Health; members will be drawn from a number of groups and organisations, including the HRA. The remit of the Regenerative Medicine Expert Group will include a role to monitor the effect of regulation on the development of regenerative medicines in the UK.

More generally, the HRA is working in partnership with a range of organisations to improve the environment for research in the UK. Please refer to our projects and plans pages for more information.

During 2012-13, the House of Lords Science and Technology Committee held an inquiry into regenerative medicine in the UK. For more information about the inquiry, the resulting report and the HRAs responses please use the links below:

UK Stem Cell Toolkit [external link]This toolkit is intended to be a reference tool for those who wish to develop a programme of human stem cell research and manufacture, including clinical applications. It applies only to the regulation of human stem cells and their use in the laboratory and clinical settings. The toolkit provides regulatory routemaps that are specific to individual stem cell projects. It does this by using your responses to questions when you start using the toolkit.

Clinical Trials Toolkit [external link]This toolkit provides practical advice to researchers in designing and conducting publicly funded clinical trials in the UK. It provides information on best practice and outlines the current legal and practical requirements for conducting clinical trials. The toolkit is primarily focused on Clinical Trials of Investigational Medicinal Products (CTIMPs) and the regulatory environment and requirements associated with these. However researchers and R&D staff working on trials in other areas will also find useful information and guidance of relevance to the wider trials environment.

Cell Therapy Catapult [external link]The Cell Therapy Catapult was established in 2012 to grow the UK cell therapy industry. It was set up to help businesses take innovative ideas through to commercialisation. The website has specific regulatory resource pages, which include an overview of the relevant regulations for cell therapy.

MHRA Innovation Office [external link]The MHRA Innovation Office helps organisations that are developing innovative medicines, medical devices or using novel manufacturing processes to navigate the regulatory processes in order to be able to progress their products or technologies. Examples of innovative products include Advanced Therapy Medicinal Products (ATMPs), nanotechnology, stratified medicines, novel drug/device combinations, and advanced manufacturing.

UK Regenerative Medicine Platform (UKRMP) [external link]The Medical Research Council (MRC), Biotechnology and Biological Sciences Research Council (BBSRC) and the Engineering and Physical Science Research Council (EPSRC) have established the UKRMP to address the challenges associated with translating scientific discoveries towards clinical impact.

UK Stem Cell Bank [external link]The UK Stem Cell Bank was established to provide a repository of human embryonic, foetal and adult stem cell lines as part of the UK governance for the use of human embryos for research. Its role is to provide quality controlled stocks of these cells that researchers worldwide can rely on to facilitate high quality and standardised research. It also prepares stocks of EUTCD-Grade cell lines for use as starting materials for the development of cellular therapies. The UK Stem Cell Bank is hosted by NIBSC [external link], which is part of the MHRA.

UK Trade & Investment (UKTI) Life Science Investment Organisation (LSIO) [external link]This dedicated unit within UKTI is intended to support overseas companies to invest and expand in the UK from the earliest research and development collaborations through to clinical trials, commercial operations and partnerships.

Knowledge Transfer Network (KTN) Regenerative Medicine Priority Area [external link]This is an official group within the Healthtechnologies and Medicine Knowledge Transfer Network (KTN). Knowledge Transfer Networks have been set up by the Technology Strategy Board (TSB) to facilitate collaboration and stimulate innovation by bringing together people from a range of organisations with a variety of expertise.

DEFRA Advisory Committee on Releases to the Environment (ACRE) [external link]

HSE Scientific Advisory Committee on Genetically Modified Organisms (Contained Use) (SACGM (CU) [external link].

MHRAs Clinical Trials, Biologicals and Vaccines Expert Advisory Group[external link]

Regenerative Medicine Expert Group [external link]

Visit link:
Regenerative Medicine - Health Research Authority

Posted in Regenerative Medicine | Comments Off on Regenerative Medicine – Health Research Authority

Everything You Wanted to know about Stem Cell Therapy …

Posted: October 1, 2017 at 6:48 am

The BIG DAY arrived and I brought Finley in for her appointment. She ate and did everything as normal.I was anxious simply because, I'm a mom. I thought, "What if she has some crazy reaction and dies?!" My husband smiled and said, "No one has ever died from stem cell treatments. It's like getting a huge boost of amino acids injected into your body. They are super nutrients! It's the medicine of the future, we are so lucky to be doing this for Finley- it's awesome!" He's always been the optimistic type. Let it be a testament as to how you can KNOW something is good and still be anxious. That's motherhood at it's finest.

About 30 minutes before the appointment she took a dose of her prescription Diazepam. Which I really hate giving to her, even though it's prescribed for her to be taking nightly (it can help with muscle spasms - but thankfully she doesn't have them). If she were to be doing this in a hospital, it's the same medication they would give her before they administer the IV to be putting her under anesthesia. It brought her to a nice, calm, and happy place.

She was very relaxed, but still watched intently as the staff positioned themselves around her. The Doctor administered the IV. Once everything was situated, I feel like he could sense my heart beating out of my chest. He held the large syringe of Stem Cells and said, "Let's Pray first." It was such a beautiful and calming prayer, his heart for Christ is just so amazing.He administered the Stem Cells into her IV, and then took a small amount and sprayed it into her nose. He told me that studies show how the cells will multiply about a dozen times or more once they are in the body, and that administering through the nasal cavity ensures they penetrate into the brain -where her injury is. (Which he also mentioned in his initial message.)She didn't love that part, but who loves having an odd smelling liquid sprayed up their nose? It does have a very distinct scent.

I asked about side effects again.The only side effect would be if she were allergic to the Sulfa that the cells were stored in. Some patients reported headaches.Sulfa is common in antibiotics, which she's taken- so I brought Benadryl just in case (Mama Bear on duty)- but we were confident she was going to be just fine. (She was. Thank you Lord.)

Go here to read the rest:
Everything You Wanted to know about Stem Cell Therapy ...

Posted in Stem Cell Therapy | Comments Off on Everything You Wanted to know about Stem Cell Therapy …

Turning Skin Cells Into Brain Cells – 06/28/2012

Posted: October 1, 2017 at 6:48 am

Johns Hopkins researchers, working with an international consortium, say they have generated stem cells from skin cells from a person with a severe, early-onset form of Huntingtons disease (HD), and turned them into neurons that degenerate just like those affected by the fatal inherited disorder.

By creating HD in a dish, the researchers say they have taken a major step forward in efforts to better understand what disables and kills the cells in people with HD, and to test the effects of potential drug therapies on cells that are otherwise locked deep in the brain.

Although the autosomal dominant gene mutation responsible for HD was identified in 1993, there is no cure. No treatments are available even to slow its progression.

The research, published in the journal Cell Stem Cell, is the work of a Huntingtons Disease iPSC Consortium, including scientists from the Johns Hopkins University School of Medicine in Baltimore, Cedars-Sinai Medical Center in Los Angeles and the University of California, Irvine, as well as six other groups. The consortium studied several other HD cell lines and control cell lines in order to make sure results were consistent and reproducible in different labs.

The general midlife onset and progressive brain damage of HD are especially cruel, slowly causing jerky, twitch-like movements, lack of muscle control, psychiatric disorders and dementia, and eventually death. In some cases (as in the patient who donated the material for the cells made at Johns Hopkins), the disease can strike earlier, even in childhood.

Having these cells will allow us to screen for therapeutics in a way we havent been able to before in Huntingtons disease, says Christopher A. Ross, M.D., Ph.D., a professor of psychiatry and behavioral sciences, neurology, pharmacology and neuroscience at the Johns Hopkins University School of Medicine and one of the studys lead researchers. For the first time, we will be able to study how drugs work on human HD neurons and hopefully take those findings directly to the clinic.

Ross and his team, as well as other collaborators at Johns Hopkins and Emory University, are already testing small molecules for the ability to block HD iPSC degeneration. These small molecules have the potential to be developed into novel drugs for HD.

The ability to generate from stem cells the same neurons found in Huntingtons disease may also have implications for similar research in other neurodegenerative diseases such as Alzheimers and Parkinsons.

To conduct their experiment, Ross took a skin biopsy from a patient with very early onset HD. When seen by Ross at the HD Center at Hopkins, the patient was just seven years old. She had a very severe form of the disease, which rarely appears in childhood, and of the mutation that causes it. Using cells from a patient with a more rapidly progressing form of the disease gave Ross team the best tools with which to replicate HD in a way that is applicable to patients with all forms of HD.

Her skin cells were grown in culture and then reprogrammed by the lab of Hongjun Song, Ph.D., a professor at Johns Hopkins Institute for Cell Engineering, into induced pluripotent stem cells. A second cell line was generated in an identical fashion in Dr. Rosss lab from someone without HD. Simultaneously, other HD and control iPS cell lines were generated as part of the NINDS funded HD iPS cell consortium.

Scientists at Johns Hopkins and other consortium labs converted those cells into generic neurons and then into medium spiny neurons, a process that took three months. What they found was that the medium spiny neurons deriving from HD cells behaved just as they expected medium spiny neurons from an HD patient would. They showed rapid degeneration when cultured in the lab using basic culture medium without extensive supporting nutrients. By contrast, control cell lines did not show neuronal degeneration.

These HD cells acted just as we were hoping, says Ross, director of the Baltimore Huntington's Disease Center. A lot of people said, Youll never be able to get a model in a dish of a human neurodegenerative disease like this. Now, we have them where we can really study and manipulate them, and try to cure them of this horrible disease. The fact that we are able to do this at all still amazes us.

Specifically, the damage caused by HD is due to a mutation in the huntingtin gene (HTT), which leads to the production of an abnormal and toxic version of the huntingtin protein. Although all of the cells in a person with HD contain the mutation, HD mainly targets the medium spiny neurons in the striatum, part of the brains basal ganglia that coordinates movement, thought and emotion. The ability to work directly with human medium spiny neurons is the best way, researchers believe, to determine why these specific cells are susceptible to cell stress and degeneration and, in turn, to help find a way to halt progression of HD.

Much HD research is conducted in mice. And while mouse models have been helpful in understanding some aspects of the disease, researchers say nothing compares with being able to study actual human neurons affected by HD.

For years, scientists have been excited about the prospect of making breakthroughs in curing disease through the use of stem cells, which have the remarkable potential to develop into many different cell types. In the form of embryonic stem cells, they do so naturally during gestation and early life. In recent years, researchers have been able to produce induced pluripotent stem cells (iPSCs), which are adult cells (like the skin cells used in Rosss experiments) that have been genetically reprogrammed back to the most primitive state. In this state, under the right circumstances, they can then develop into most or all of the 200 cell types in the human body.

The other members of the research consortium include the University of Wisconsin School of Medicine, Massachusetts General Hospital and Harvard Medical School, the University of California, San Francisco, Cardiff University the Universita degli Studi diMilano and the CHDI Foundation.

Primary support for this research came from an American Recovery and Reinvestment Act (ARRA) grant (RC2-NS069422) from the National Institutes of Healths National Institute of Neurological Disorders and Stroke and a grant from the CHDI Foundation, Inc.

Other Johns Hopkins researchers involved in this study include Sergey Akimov, Ph.D.; Nicolas Arbez, Ph.D.; Tarja Juopperi, D.V.M., Ph.D.; Tamara Ratovitski; Jason H. Chiang; Woon Roung Kim; Eka Chighladze, M.S., M.B.A.; Chun Zhong; Georgia Makri; Robert N. Cole; Russell L. Margolis, M.D.; and Guoli Ming, M.D., Ph.D.

Read the original:
Turning Skin Cells Into Brain Cells - 06/28/2012

Posted in Georgia Stem Cells | Comments Off on Turning Skin Cells Into Brain Cells – 06/28/2012

Molecular Genetics and Genomics Program – Wake Forest …

Posted: October 1, 2017 at 6:47 am

The Molecular Genetics and GenomicsProgram in the Wake Forest School of Medicine is an interdisciplinary research and PhD training program composed of a diverse group of investigators employing molecular and genetic approaches to biomedical research.

The Program includes molecular biologists from each of the basicscience departments of the School of Medicine as well as clinical facultyinvolved in laboratory research. Participating investigators include facultyfrom the departments of Biochemistry, Cancer Biology, Neurobiology and Anatomy,Medicine, Microbiology and Immunology, Pathology, Pediatrics, Physiology andPharmacology, and Surgery. Many program faculty are also members of theComprehensive Cancer Center of Wake Forest University.

Part of the first-year Molecular & Cellular Biosciences (MCB)track, the objective of the PhD training program is to provide aninterdisciplinary curriculum that emphasizes the detailed analysis of fundamentalbiological processes using the tools of molecular biology and genetics.Individualized programs of study are designed to train students for independentcareers in research and teaching. The first year MCB curriculum provides broadexposure to the fundamentals of molecular and cellular biology, biochemistry,and microbiology.

After the completion of the first year in the MCB track, studentsthat select a Molecular Genetics & Genomics research advisor beginspecialization in the research area of that laboratory. Areas of activeinvestigation include the genetics of complex diseases, genetic epidemiology,epigenetics, and bioinformatics.

Click here to obtain information on the APPLICATION PROCESS for the Molecular Genetics and GenomicsProgram.

See more here:
Molecular Genetics and Genomics Program - Wake Forest ...

Posted in Molecular Genetics | Comments Off on Molecular Genetics and Genomics Program – Wake Forest …

Adult Stem Cell Therapy in Utah Docere Clinics

Posted: October 1, 2017 at 6:47 am

Stem cells, specifically mesenchymal stem cells (MSCs), have been called patient-specific drug stores for injured tissues because of their broad range of healing abilities. MSCs are directly responsible for healing damaged tissues after injury. Upon encountering damaged tissue, they release proteins that decrease inflammation, kill invading microbes, and trigger the growth of new connective tissues and blood vessels.In the case of severe damage and cell death, MSCs have the ability to turn into healthy versions of damaged or destroyed cells that they encounter.

When we take MSCs from your own bone marrow, from your own fat, or from both, concentrate and/or isolate them, and then inject them directly into your problem area, we trick your body into thinking that there has been a new injury without actually causing any tissue insult, and you get a second chance at healing. In the case of advanced osteoarthritis where the population of stem cells has been depleted, we are repopulating the area with stem cells, and thereby restoring the bodys natural ability to heal itself.

Docere Clinics is an affiliate member of the Cell Surgical Network(CSN).It is the belief of the CSN that the most ethical approach to stem cell therapy is under the umbrella of IRB approved research protocols. An IRB is an Institutional Review Board;an organization of members responsible for approving and overseeing research on humans. IRBs are approved under the auspices of the U.S. Department of Human Research Protection. As such, our patients understand the investigational nature of our activities, are provided appropriate informed consents, and are followed continuously on an online database to chart their progress or any issues of concern. The efforts of the CSN will provide safety data,demonstrate effectiveness of treatments, and help to improve treatment programs going forward.

More here:
Adult Stem Cell Therapy in Utah Docere Clinics

Posted in Utah Stem Cells | Comments Off on Adult Stem Cell Therapy in Utah Docere Clinics

Hidden In Plain Sight – 4 Movies That Expose The Globalist …

Posted: September 30, 2017 at 12:47 am

by Gregg Prescott, M.S.Editor, In5D.com

While there are many movies that expose the globalist agenda, four movies particularly caught my attention.

There seems to be several agendas going on simultaneously, such as the alien agenda and the New World Order agenda, but one other agenda is being shoved down our collective throats for at least 30 years: The transhumanism agenda.

The premise of transhumanism dates as far back as mans first search for the elixir to immortality and in recent years has segued into glorifying the idea of combining man with machine.

IMDb describes Chappie as:

In the near future, crime is patrolled by an oppressive mechanized police force. But now, the people are fighting back. When one police droid, Chappie, is stolen and given new programming, he becomes the first robot with the ability to think and feel for himself. As powerful, destructive forces start to see Chappie as a danger to mankind and order, they will stop at nothing to maintain the status quo and ensure that Chappie is the last of his kind.

Chappie is glorifying the transhumanism agenda in conjunction with artificial intelligence where people will soon be offered to live as immortal gods in exchange for being hooked up to the matrix, which inevitably, will make these same people perpetual, subservient slaves.

We are starting to see the beginning of this through digital tattoos, smart tattoos, ingestible RFID chips, and nanoparticle RFIDs. Globalist shill Regina Dugan, former DARPA head who now leads advanced research for Motorola stated, It may be true that 10-20 year olds dont want to wear a watch on their wrists, but you can be sure that theyll be far more interested in wearing an electronic tattoo if only to piss off their parents.

For many people, The Matrix was just another science fiction movie but for even more people, this is the initial movie that truly woke the masses out of their collective stupor.

IMDb: A computer hacker learns from mysterious rebels about the true nature of his reality and his role in the war against its controllers.

Thomas A. Anderson is a man living two lives. By day he is an average computer programmer and by night a hacker known as Neo. Neo has always questioned his reality, but the truth is far beyond his imagination. Neo finds himself targeted by the police when he is contacted by Morpheus, a legendary computer hacker branded a terrorist by the government. Morpheus awakens Neo to the real world, a ravaged wasteland where most of humanity have been captured by a race of machines that live off of the humans body heat and electrochemical energy and who imprison their minds within an artificial reality known as the Matrix. As a rebel against the machines, Neo must return to the Matrix and confront the agents: super-powerful computer programs devoted to snuffing out Neo and the entire human rebellion.

More and more people are beginning to realize the many truths in this movie which basically shows how we are living in a simulated reality while our bodies are living as an energy source for our overlords.

Similar to Chappie, transhumanism takes precedent as a means of going in and out of the matrix. While caught within the matrix, we all assume that this is real but relatively few people question why we need to work for money and cannot comprehend the premise behind the question, If there was no such thing as money, what would you be doing with your life? Weve been brainwashed for millennia about living in this false reality constructed to keep us living in subservience, control and conformity to a system designed to keep us living in fear as economic slaves.

When you look at it from this perspective, does it make sense to waste the majority of your life working some job that you hate for a boss whos an a*hole, only to get that 1 or 2 weeks off a year to enjoy as a vacation while your literally recharge your battery? Theres a reason we look forward to the weekend because by the weekend, we are weakened.

Mark Passio does an amazing job analyzing The Matrix trilogy:

IMDbs description of Network: A television network cynically exploits a deranged former anchors ravings and revelations about the news media for its own profit.

In the 1970s, terrorist violence is the stuff of networks nightly news programming and the corporate structure of the UBS Television Network is changing. Meanwhile, Howard Beale, the aging UBS news anchor, has lost his once strong ratings share and so the network fires him. Beale reacts in an unexpected way. We then see how this affects the fortunes of Beale, his coworkers (Max Schumacher and Diana Christensen), and the network.

The star of the film, Howard Beale, even hinted at transhumanism:

The whole world is becoming humanoid creatures that look human, but arent. The whole world, not just us.

The bottom line is how the nightly news influences and persuades public opinion, even through blatant lies. Youll never feel good after watching the nightly news. Why? Because when you live in the lower vibration of fear, you can be easily controlled and manipulated. The current terrorist agenda is the perfect ploy by the globalists because its a war that can never be won. Additionally, people will gladly give up their civil liberties and freedom in exchange for perceived protection by the government to fight these non-existent entities.

David Icke calls this Problem. Reaction. Solution in which the government creates a problem through false flags, we react by saying the government needs to address the problem and the government has a solution to the problem, which ALWAYS involves the loss of civil liberties and freedom.

We are just starting to see a group of disgruntled reporters leave the industry because they do not agree with how the news is scripted or the propaganda that is being pushed by the CIA in order to influence public opinion regarding everything from how well the economy is doing to why we should start yet another war. Unfortunately, there are plenty of buffoons in search of fame and notoriety (ego) who are willing to take the places of these reporters who have left the business, and they will conform to whatever their overlords desire, even if that means hurting their friends and family by reporting lies to the masses.

John Carpenters 1988 cult classic, They Live combines an alien agenda with how the mainstream media is brainwashing the masses.

IMDb describes the movie as A drifter discovers a pair of sunglasses that allow him to wake up to the fact that aliens have taken over the Earth.

Nada, a down-on-his-luck construction worker, discovers a pair of special sunglasses. Wearing them, he is able to see the world as it really is: people being bombarded by media and government with messages like Stay Asleep, No Imagination, Submit to Authority. Even scarier is that he is able to see that some usually normal-looking people are in fact ugly aliens in charge of the massive campaign to keep humans subdued.

An intriguing part of the movie is when the aliens throw a party for their human collaborators who agree to push the alien agenda. This is very reminiscent of lobbyists who push agendas for Monsanto, Big Pharma, etc.. The bottom line is that if you support the alien agenda, you will be generously compensated to keep your mouth shut. Does this sound familiar to you?

The Terminator

IMDb:

A cyborg is sent from the future on a deadly mission. He has to kill Sarah Connor, a young woman whose life will have a great significance in years to come. Sarah has only one protector Kyle Reese also sent from the future. The Terminator uses his exceptional intelligence and strength to find Sarah, but is there any way to stop the seemingly indestructible cyborg?

Lucy

IMDb:

It was supposed to be a simple job. All Lucy had to do was deliver a mysterious briefcase to Mr. Jang. But immediately Lucy is caught up in a nightmarish deal where she is captured and turned into a drug mule for a new and powerful synthetic drug. When the bag she is carrying inside of her stomach leaks, Lucys body undergoes unimaginable changes that begins to unlock her minds full potential. With her new-found powers, Lucy turns into a merciless warrior intent on getting back at her captors. She receives invaluable help from Professor Norman, the leading authority on the human mind, and French police captain Pierre Del Rio.

While it may seem like a glamorous idea to have infinite knowledge, there will be a price to pay. For example:

Its not enough to expose these agendas. One needs to be cognizant of what is being forced upon us and be willing to make decisions that are proactive, such as refusing any RFID chip implantation or simply not buying into the false promises of how great your life will be as a cyborg. By choosing artificial intelligence, there is no spiritual progression for the soul, if any part of the soul remains.

The power of thought can also create the world you want to see. Try envisioning a world without transhumanism, money or globalist agendas. Replace the negative things in this world, such as nuclear energy, gas or coal, with free energy. We have the ability RIGHT NOW to create a world where everyone can live in abundance and prosperity without the need for economic subservience.

You were born as a PERFECT soul and upon returning to the Creator, you will remain in complete perfection without the need for artificial intelligence or transhumanism.

Follow In5D on Facebook!

Click here for more articles by Gregg Prescott!

About the Author:Gregg Prescott, M.S. is the founder and editor of In5D and BodyMindSoulSpirit. You can find his In5D Radio shows on the In5D Youtube channel. He is a visionary, author, a transformational speaker, and promotes spiritual, metaphysical and esoteric conferences in the United States through In5dEvents. His love and faith for humanity motivates him to work in humanitys best interests 12-15+ hours a day, 365 days a year. Please like and follow In5D on Facebook as well as BodyMindSoulSpirit on Facebook!

Tags: 4 Movies That Expose The Globalist Agenda, agenda, alien agenda, artificial intelligence, chappie, David Icke, gregg prescott, Hidden In Plain Sight, Hidden In Plain Sight - 4 Movies That Expose The Globalist Agenda, if there was no such thing as money, lucy, movie, movies, network, NEW WORLD ORDER, propaganda, RFID chip, the matrix, the terminator, they live, transhumanism, transhumanism agenda, vibration of fear

Read the rest here:
Hidden In Plain Sight - 4 Movies That Expose The Globalist ...

Posted in Transhumanism | Comments Off on Hidden In Plain Sight – 4 Movies That Expose The Globalist …

Aegean Medical by Dr. Angelo Tellis

Posted: September 28, 2017 at 8:49 pm

Dr. Angelo TellisCosmetic Surgeon and Regenerative Medicine Specialist

Aegean Medical offers all natural, high tech procedures with a European flair to meet your cosmetic and orthopedic needs! Aegean procedures are less invasive than traditional plastic or orthopedicsurgery with much less downtime and recovery.

Aegean Cosmeticspecializes in Liposuction, Lipotransfernatural breast and buttock augmentations, Scarless Breast Reductions, and powerful skin care treatments like PRP (platelet rich plasma) facials, Dermapen microneedling, and RF (radio frequency) skin tightening. Aegean Cosmetic can also perform PRP treatment to help promote hair restorationas well.

Aegean Orthopedic provides treatments using yourbodys own stem cells and PRP to repair damage and regrow cartilage for knees, shoulders, hips, and a variety of otherconditions where degeneration or tissue damage has occurred. Orthopedic treatments are normally completed in the office setting within 1-2 hours!

Advantages Tumescent liposuction and breast enhancement in one procedure. All natural- nothing artificial is used. Safe and gentle procedure. Enhancement looks and feels like natural breasts. Future breast feeding not affected. Rapid recovery. Permanent, selective treatment of problem areas with smooth, even results. Virtually no scarring at insertion sites. Significantly reduced risk of complications. Comfortable outpatient procedure. Less bleeding, bruising and swelling.

Fourlocations to serve you Aegean Medical is located in Morehead City, New Bern, Jacksonville, and CaryNC and operates under the Crystal Coast Pain Management and Azura Skin Caresystem and supporting providers .

Read the rest here:
Aegean Medical by Dr. Angelo Tellis

Posted in Regenerative Medicine | Comments Off on Aegean Medical by Dr. Angelo Tellis

Research | Lupus Foundation of America

Posted: September 28, 2017 at 8:47 pm

The LFA believes expanding stem cell research will accelerate the pace of discovery on the potential therapeutic benefits of stem cells and help basic and clinical researchers learn how stem cells can be used to develop life-saving treatments.

Stem cells possess the potential to develop into many different types of cells in the body. They serve as a repair system for the body. Mesenchymal stem cells are found in mature tissues that have already developed. The body uses these cells to replace other cells that die off throughout the normal course of life. As they are not from fetal tissue, these stem cells do not have the same ethical concerns or restrictions that embryonic stem cells do. Current research in lupus focuses on mesenchymal stem cells.

Mesenchymal stem cells (MSC) are derived from bone marrow, umbilical cords or other tissues and are anti-inflammatory. These anti-inflammatory cells have unique properties that make them attractive as therapy for autoimmune diseases. Unlike with other stem cells, MSCs lack the properties that enable the immune system to detect them as being foreign. Therefore:

MSCs have been studied in inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and scleroderma. In these studies, MSC treatment has been found to be effective and only minimal side effects reported.

Pioneering researchers from China have studied MSC treatment in over 200 people with lupus who had been unresponsive to standard lupus therapies. Preliminary results show that:

While the findings are groundbreaking, there was no control group in these early studies. This means that every participant received the stem cell treatment plus standard lupus therapies. A controlled trial is necessary to ensure that individuals who receive the MSC therapy plus standard lupus therapies do indeed respond better than closely matched participants who only receive standard therapy.

This first-of-its-kind phase II clinical trial of mesenchymal stem cells for the treatment of moderate to severe lupus could help lower medication dosage, diminish the long-term effects of lupus, stop damage to vital organs, and save lives. The trial is led by Drs. Gary Gilkeson and Diane Kamen from the Medical University of South Carolina and will be conducted at six research institutions around the country.

Stem cell therapy holds promise as a safe and effective alternative for people with lupus who do not benefit from the current treatments available. Mesenchymal stem cell research has provided hope to people with formerly incurable and devastating conditions, including Parkinsons disease, leukemia, heart diseases, multiple sclerosis, juvenile diabetes and osteoarthritis, as well as 80 other diseases.

Previous research using this type of therapy for lupus and other diseases reported minimal side effects. Like every potential new therapy, this treatment must be tested. We remain hopeful this procedure will prove successful and be included in the arsenal of treatments for lupus.

Only one drug is available that was developed specifically to treat lupus. It took more than 50 years for a new drug to be approved for lupus and it does not work for everyone. We need treatments for lupus, and this study provides hope for the future.

We are rallying support for this promising research so it will get the attention and research funding it deserves from public and private sources.

Previous research on mesenchymal stem cells has been promisingbut more testing is needed. Thats why we need your support. We are asking donors to consider supporting this effort with a special contribution. Our goal is to raise $500,000. The funding will enable researchers to treat initial participants. Ultimately, the study will be expanded through potential funding from the National Institutes of Health (NIH) and other sources.

To learn more about this study and determine if you are eligible to participate, visit the MSCs in SLE Trial page on ClinicalTrials.gov.

The LFA thus far has awarded 11 grants to advance basic and clinical adult stem cell research as a treatment for lupus. Learn more about all the investigators we have funded for stem cell research.

See the article here:
Research | Lupus Foundation of America

Posted in South Carolina Stem Cells | Comments Off on Research | Lupus Foundation of America

Utah Stem Cells – Cottonwood Heights, UT | Groupon

Posted: September 26, 2017 at 7:45 am

Why is Stem Cell Prolotherapy better than alternative methods of treating chronic joint pain?

The procedure lasts about 3040 minutes, using local anesthetic with very little discomfort, and after it is completed you will be able to walk out of the office and drive yourself home. This is in contrast to prolonged hospital stays with extensive down time and expense associated with various surgical procedures, including total knee replacements. The average cost of a total knee replacement in the U.S. is $40,000, and often associated with mediocre results, especially with regard to functionality. Stem Cell Prolotherapy offers a much better solution with potentially better results, especially mobility, at a fraction of the cost. There are other treatment modalities sometimes used to lubricate the knee joint, such as Hyaluronate, known by the brand names, "Synvisc" or "Euflexxa". The problem with these is that they are only a temporary solution, which at best will only last for about six months before the procedure will need to be repeated. This is in stark contrast to the permanent healing and regeneration, which is achieved with the Stem Cell Prolotherapy. However, Hyaluronate can be used in conjunction with the Stem Cell Prolotherapy so that you can enjoy the benefits of both therapies, if you choose.

Continue reading here:
Utah Stem Cells - Cottonwood Heights, UT | Groupon

Posted in Utah Stem Cells | Comments Off on Utah Stem Cells – Cottonwood Heights, UT | Groupon

Page 1,454«..1020..1,4531,4541,4551,456..1,4601,470..»